News & Press Releases

Capricorn’s latest publication Protective efficacy of the UniFluVec influenza vaccine vector against the highly pathogenic influenza...

We are pleased to highlight a significant new publication from  Capricorn , entitled  UniFluVec influenza vector induces heterosubtypic...

Capricorn Technologies, together with its subsidiary NuCell GmbH (Tulln, Austria), has reached a significant milestone in the development...